FR2274290A2 - Medicament a base d'alpha-hydroxy-acides analogues d'amino-acides, en association avec des acides alpha-cetoniques analogues d'amino-acides, pour favoriser la synthese des proteines et supprimer la formation de l'uree dans l'organisme - Google Patents

Medicament a base d'alpha-hydroxy-acides analogues d'amino-acides, en association avec des acides alpha-cetoniques analogues d'amino-acides, pour favoriser la synthese des proteines et supprimer la formation de l'uree dans l'organisme

Info

Publication number
FR2274290A2
FR2274290A2 FR7511523A FR7511523A FR2274290A2 FR 2274290 A2 FR2274290 A2 FR 2274290A2 FR 7511523 A FR7511523 A FR 7511523A FR 7511523 A FR7511523 A FR 7511523A FR 2274290 A2 FR2274290 A2 FR 2274290A2
Authority
FR
France
Prior art keywords
acids
alpha
amino
analogues
urea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7511523A
Other languages
English (en)
Other versions
FR2274290B2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Publication of FR2274290A2 publication Critical patent/FR2274290A2/fr
Application granted granted Critical
Publication of FR2274290B2 publication Critical patent/FR2274290B2/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7511523A 1974-04-15 1975-04-14 Medicament a base d'alpha-hydroxy-acides analogues d'amino-acides, en association avec des acides alpha-cetoniques analogues d'amino-acides, pour favoriser la synthese des proteines et supprimer la formation de l'uree dans l'organisme Granted FR2274290A2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46125974A 1974-04-15 1974-04-15

Publications (2)

Publication Number Publication Date
FR2274290A2 true FR2274290A2 (fr) 1976-01-09
FR2274290B2 FR2274290B2 (fr) 1979-03-16

Family

ID=23831817

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7511523A Granted FR2274290A2 (fr) 1974-04-15 1975-04-14 Medicament a base d'alpha-hydroxy-acides analogues d'amino-acides, en association avec des acides alpha-cetoniques analogues d'amino-acides, pour favoriser la synthese des proteines et supprimer la formation de l'uree dans l'organisme

Country Status (6)

Country Link
US (1) US4100160A (fr)
BE (1) BE827890A (fr)
CA (1) CA1057198A (fr)
FR (1) FR2274290A2 (fr)
GB (1) GB1511302A (fr)
NL (1) NL7504408A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2454434A1 (fr) * 1979-04-18 1980-11-14 Univ Johns Hopkins Sels mixtes d'acides amines essentiels ou semi-essentiels et de produits analogues, exempts d'azote, de ces acides, et leur utilisation dans le traitement de desordres renaux et hepatiques

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4637899A (en) * 1984-01-30 1987-01-20 Dowell Schlumberger Incorporated Corrosion inhibitors for cleaning solutions
US4619923A (en) * 1985-01-14 1986-10-28 The Rockefeller University Metal protoporphyrins in the control of tryptophan metabolism
US4677121A (en) * 1985-01-22 1987-06-30 The Johns Hopkins University Method of inhibiting muscle protein degradation
US4762854A (en) * 1986-01-24 1988-08-09 Vet-A-Mix Method of reducing urine pH
SE462463B (sv) * 1988-12-02 1990-07-02 Decken Alexandra V D Livs- och fodermedel innehaallande ketosyror
US5026721A (en) * 1989-06-05 1991-06-25 Dudrick Stanley J Amino acid nutritional supplement and regimen for enhancing physical performance through sound nutrition
US4957938A (en) * 1989-06-21 1990-09-18 Abbott Laboratories Nutritional formulation for the treatment of renal disease
US5374651A (en) * 1991-09-27 1994-12-20 Board Of Regents, The University Of Texas System Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives
US5350766A (en) * 1992-12-18 1994-09-27 New York Medical College Method for the prevention and/or palliation of the complications of diabetes using N-alpha orginine acetyl
US5571783A (en) * 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
US5591736A (en) * 1995-07-03 1997-01-07 The Johns Hopkins University Method of retarding the progression of chronic renal failure
AU5813598A (en) * 1997-01-06 1998-08-03 Walser, Mackenzie Supplement for dialysis patients
US6797289B2 (en) * 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US20070141181A1 (en) * 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
AU3308999A (en) 1998-02-27 1999-09-15 Nutramax Laboratories, Inc. L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
US20010000472A1 (en) * 1998-02-27 2001-04-26 Nutramax Laboratories, Inc. L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
ITTO20020672A1 (it) * 2002-07-26 2004-01-26 Medestea Res And Production S Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
FI20045395A (fi) * 2004-10-21 2006-04-22 Elmomed Ltd Oy Ravintoainelisä ja sen käyttö
US20090156647A1 (en) * 2007-12-12 2009-06-18 Iovate T. & P. Inc. Method for maintaining physiological pH levels during intensive physical exercise
WO2009073944A1 (fr) * 2007-12-12 2009-06-18 Iovate T. & P. Inc. Utilisation de pyridoxine alpha-hydroxyisocaproate pour réduire l'acidose métabolique et l'accumulation d'ammoniac
US8242054B2 (en) * 2008-02-19 2012-08-14 Snow Brand Seed Co., Ltd. Plant growth regulator composition
US8173181B2 (en) 2009-11-09 2012-05-08 Bio-Engineered Supplements & Nutrition, Inc. Method and composition for improved anabolism
US20140134658A1 (en) * 2010-05-21 2014-05-15 Notrhwestern University, An Illinois Not For Profit Corporation Psa enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness
US20120034638A1 (en) * 2010-05-21 2012-02-09 Michael Ahrens Electrochemical assay for the detection of enzymatically active PSA
BR112013026706A2 (pt) * 2011-04-18 2016-12-27 Nestec Sa composições nutricionais compreendendo ácido alfa-hidroxi-isocaproico
EP3716966A4 (fr) * 2017-11-29 2021-08-18 Hull, Edgar, L., Jr. Compositions d'alpha-cétoacides pour le traitement de l'hypoalbuminémie
US11484579B2 (en) 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
DK3603419T3 (da) 2018-07-31 2021-09-13 Evonik Operations Gmbh Blandinger af forgrenede ketosyrer (bcka) og fremgangsmåde til fremstilling af sådanne blandinger

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2457820A (en) * 1945-12-27 1949-01-04 Merck & Co Inc Amino acid solution and process for preparing the same
US3764703A (en) * 1969-11-07 1973-10-09 Astra Ab Amino acid mixture for use in treatment of uremic conditions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2454434A1 (fr) * 1979-04-18 1980-11-14 Univ Johns Hopkins Sels mixtes d'acides amines essentiels ou semi-essentiels et de produits analogues, exempts d'azote, de ces acides, et leur utilisation dans le traitement de desordres renaux et hepatiques

Also Published As

Publication number Publication date
BE827890A (fr) 1975-07-31
US4100160A (en) 1978-07-11
NL7504408A (nl) 1975-10-17
CA1057198A (fr) 1979-06-26
GB1511302A (en) 1978-05-17
FR2274290B2 (fr) 1979-03-16

Similar Documents

Publication Publication Date Title
FR2274290A2 (fr) Medicament a base d'alpha-hydroxy-acides analogues d'amino-acides, en association avec des acides alpha-cetoniques analogues d'amino-acides, pour favoriser la synthese des proteines et supprimer la formation de l'uree dans l'organisme
FR2285896A1 (fr) Preparation pharmaceutique destinee a l'administration dans la cavite buccale
FR2332263A1 (fr) Composes azotes de l'uree utilisables comme catalyseurs dans la synthese de polyurethannes
BE820253A (fr) Esters d'amino acides
BE832097A (fr) Medicaments en granules friables propres a l'inhalation
BE803567A (fr) Composition et methode destinees a favoriser la synthese des proteines et la suppression de la formation d'uree dans l'organisme
BE789830A (fr) Procede de preparation de nouveaux derives cycliques d'uree et de leurssels avec des acides pharmacologiquement acceptables
BE826982A (fr) Medicament en vue d'eviter les symptomes uremiques et son procede de preparation
FR2315916A2 (fr) Melanges therapeutiques comprenant des analogues alpha hydroxy acides d'acides amines essentiels et leur administration a l'homme en vue de l'amelioration de la synthese proteique et la suppression de la formation d'uree
FR2277577A1 (fr) Derives de l'acide prostanoique et medicaments qui en renferment
FR2276283A1 (fr) Preparation d'acides carboxyliques, notamment d'a-ceto-acides
FR2283668A1 (fr) Derives de l'acide prostanoique et medicaments qui en contiennent
FR2321294A1 (fr) Derives d'acides 7b-amino-3-cephem-3-carbonylmethyl-4-carboxyliques utiles comme medicaments
BE814377A (fr) Medicaments a base d'amides d'acides aldoniques et leur procedede preparation
BE803568A (fr) Composition et methode destinees a favoriser la synthese des proteines et la suppression de la formation d'uree dans l'organisme
BE788150A (fr) Derives du thiadiazole-1,2,4, utilisables dans des produits antifongiques phytosanitaires et dans des medicaments
FR2281109A1 (fr) Amides de l'acide cinnamique, leur preparation et medicament contenant ces substances
BE830441A (fr) Nouveaux amides peptidiques d'acides 6-alkyl-ergoline-8-carboxyliques,leur preparation et leur application conne medicaments
BE833835A (fr) Nouveaux amides peptidiques d'acides 6-alkyl-ergoline-8-carboxyliques,leur preparation et leur application comme medicaments
BE769896A (fr) Nouvelle forme d'administration de medicaments insolubles
FR2276297A1 (fr) Nouvelles sulfones olefiniques, leur preparation et leur utilisation dans la synthese de produits biologiquement actifs
PH12224A (en) Sulfonyl urea derivatives and pharmaceutical preparations thereof
FR2286646A1 (fr) Derives de l'acide 2-naphtyl-butyrique a activite therapeutique
BE819833A (fr) Medicament a base de beta-1-glycoproteine
IT1214915B (it) Derivato dell'acido 4-metossiisoftalico con attivita'farmacologica in disordini tromboembolici e procedimento per la sua preparazione